Pfizer
Olena Goloborodko has extensive experience in corporate legal counsel and contract negotiation within the pharmaceutical industry. As of July 2024, Olena serves as Director & Corporate Counsel at Pfizer, previously holding the title of Associate Director Corporate Counsel. Prior to Pfizer, Olena worked at Seagen as Associate Director, Corporate Legal Counsel, and at Celgene as Associate Director in two capacities focused on global contract negotiation. Earlier experience includes a role as Senior Manager of Global Contracts and Outsourcing Management at Astellas Pharma Europe and as a Project Officer at Leiden University. Olena holds a Master of Laws in Corporate Law from Leiden University and studied Leadership and Management at the Rotterdam School of Management, Erasmus University.
This person is not in any teams
This person is not in any offices
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.